NFKB1 and colorectal carcinoma: The metabolite tyrosol inhibits CRC progression by suppressing NF-κB/hypoxia-inducible factor 1 (HIF-1) signaling, reducing ROS and inflammation (63), while indole imine and colibactin exacerbate CRC development through DNA damage (64, 65).